Ehara Y et al: Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. J Dermatol. 47(2):190-2, 2020
Espírito Santo V et al: Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. J Neurooncol. 147(2):459-63, 2020
Passos J et al: Dramatic improvement of a massive plexiform neurofibroma after administration of selumetinib. Pediatr Neurol. 105:69-70, 2020
Peyron PA et al: Fatal acute retropharyngeal hemorrhage in neurofibromatosis type 1. Forensic Sci Med Pathol. 13(4):436-440, 2017
Latham K et al: Neurofibromatosis of the head and neck: classification and surgical management. Plast Reconstr Surg. 135(3):845-55, 2015
Setabutr D et al: Neurofibromatosis of the larynx causing stridor and sleep apnea. Am J Otolaryngol. 35(5):631-5, 2014
Jett K et al: Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 12(1):1-11, 2010
Moharir M et al: Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging. 37(7):1309-17, 2010
Brems H et al: Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 10(5):508-15, 2009
Slam KD et al: Surgical considerations for the familial cancer syndrome, neurofibromatosis 1: a comprehensive review. Am Surg. 75(2):120-8, 2009
Bredella MA et al: Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol. 189(4):928-35, 2007
Poussaint TY et al: Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas. AJR Am J Roentgenol. 180(2):419-23, 2003
Ehara Y et al: Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. J Dermatol. 47(2):190-2, 2020
Espírito Santo V et al: Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience. J Neurooncol. 147(2):459-63, 2020
Passos J et al: Dramatic improvement of a massive plexiform neurofibroma after administration of selumetinib. Pediatr Neurol. 105:69-70, 2020
Peyron PA et al: Fatal acute retropharyngeal hemorrhage in neurofibromatosis type 1. Forensic Sci Med Pathol. 13(4):436-440, 2017
Latham K et al: Neurofibromatosis of the head and neck: classification and surgical management. Plast Reconstr Surg. 135(3):845-55, 2015
Setabutr D et al: Neurofibromatosis of the larynx causing stridor and sleep apnea. Am J Otolaryngol. 35(5):631-5, 2014
Jett K et al: Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 12(1):1-11, 2010
Moharir M et al: Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. Eur J Nucl Med Mol Imaging. 37(7):1309-17, 2010
Brems H et al: Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 10(5):508-15, 2009
Slam KD et al: Surgical considerations for the familial cancer syndrome, neurofibromatosis 1: a comprehensive review. Am Surg. 75(2):120-8, 2009
Bredella MA et al: Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol. 189(4):928-35, 2007
Poussaint TY et al: Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas. AJR Am J Roentgenol. 180(2):419-23, 2003
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.